{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:33:53Z","timestamp":1780914833873,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,6]]},"abstract":"<jats:p>A growing number of studies have found that the lymph node ratio (LNR) is an important indicator of prognosis in non-small-cell lung cancer (NSCLC). Impact analysis for LNR was performed for survival in patients undergoing surgery for stage III NSCLC compared to the surveillance, epidemiology and end results databank. Clinicopathological variables, such as cancer-specific survival (CSS), were taken from the surveillance epidemiology and end result databank of stage III NSCLC patients who underwent surgery, and the LNR threshold stratification of NSCLC patients was computed by X-tile. CSS was assessed by the Kaplan\u2013Meier method with CSS-independent risk factors calculated by multivariate Cox regression analysis. In total, 7011 lung cancer patients were included. Multifactorial analysis showed that LNR and positive node category had predictive value for stage III NSCLC. In patients with stage IIIA NSCLC, Kaplan\u2013Meier analysis demonstrated that patients with T1-2N2 stage had clearly superior CSS than those with T3-4N1 stage (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), which conflicted with the results from the assessment of primary tumor, lymph nodes, and metastasis\/N stage. The cutoff values for LNR were 0.31 and 0.59. Kaplan\u2013Meier analysis demonstrated that the CSS was substantially better in patients with LNR-low than in those with LNR-medium or LNR-high (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), which was also proven by multivariate competing risk regression. Subgroup analysis suggested that the survival advantage of a lower LNR was achieved in all subgroups (sex, race, etc). In stage III NSCLC, the LNR is a valuable factor for assessing prognosis, in which a higher LNR indicates a worse prognosis.<\/jats:p>","DOI":"10.1097\/md.0000000000035341","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T12:11:21Z","timestamp":1696594281000},"page":"e35341","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic value of lymph node ratio in stage III non-small-cell lung cancer: A retrospective cohort study"],"prefix":"10.1097","volume":"102","author":[{"given":"Xiang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1007\/s00405-019-05597-0","article-title":"Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer.","volume":"276","author":"Lei","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1245\/s10434-020-08616-1","article-title":"Association between lymph node ratio and survival in patients with pathological stage II\/III gastric cancer.","volume":"27","author":"Kano","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"104709","DOI":"10.1016\/j.oraloncology.2020.104709","article-title":"Prognostic value of log odds of positive lymph nodes in patients with resectable oral squamous cell carcinoma.","volume":"108","author":"Jin","year":"2020","journal-title":"Oral Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/JTO.0b013e3182829c16","article-title":"The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.","volume":"8","author":"Qiu","year":"2013","journal-title":"J Thorac Oncol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.athoracsur.2013.04.031","article-title":"Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.","volume":"96","author":"Taylor","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The eighth edition lung cancer stage classification.","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1213\/ANE.0000000000005358","article-title":"Kaplan-Meier curves, log-rank tests, and cox regression for time-to-event data.","volume":"132","author":"Schober","year":"2021","journal-title":"Anesth Analg"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/BF02598295","article-title":"Proportional hazards (Cox) regression.","volume":"8","author":"Katz","year":"1993","journal-title":"J Gen Intern Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11336-017-9572-y","article-title":"Asymptotics of AIC, BIC, and RMSEA for model selection in structural equation modeling.","volume":"82","author":"Huang","year":"2017","journal-title":"Psychometrika"},{"key":"R12-20250504","first-page":"328","article-title":"[\u201cR\u201d--project for statistical computing].","volume":"170","author":"Dessau","year":"2008","journal-title":"Ugeskr Laeger"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.21037\/jtd-21-428","article-title":"Tumor size as a predictor for prognosis of patients with surgical IIIA-N2 non-small cell lung cancer after surgery.","volume":"13","author":"Zhang","year":"2021","journal-title":"J Thorac Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ejcts\/ezt550","article-title":"Time to refine N2 staging? cN2\u03b1 and cN2\u03b2 based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.","volume":"46","author":"Matsunaga","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/JTO.0b013e31815ba24e","article-title":"Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement.","volume":"2","author":"Sakao","year":"2007","journal-title":"J Thorac Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2019.07.034","article-title":"Recommended change in the N descriptor proposed by the international association for the study of lung cancer: a validation study.","volume":"14","author":"Park","year":"2019","journal-title":"J Thorac Oncol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1148\/radiol.2021204461","article-title":"Application of N descriptors proposed by the international association for the study of lung cancer in clinical staging.","volume":"300","author":"Song","year":"2021","journal-title":"Radiology"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"n2363","DOI":"10.1136\/bmj.n2363","article-title":"Advances in systemic therapy for non-small cell lung cancer.","volume":"375","author":"Miller","year":"2021","journal-title":"BMJ"},{"issue":"10 PtA","key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ejso.2019.12.015","article-title":"Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: a multicenter observational study of a large cohort of the Chinese patients.","volume":"46","author":"Li","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e000846","DOI":"10.1136\/bmjresp-2020-000846","article-title":"Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial).","volume":"8","author":"Taylor","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"R21-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051307","article-title":"Prognostic value of tumor size in resected stage IIIA-N2 non-small-cell lung cancer.","volume":"9","author":"Chen","year":"2020","journal-title":"J Clin Med"},{"key":"R22-20250504","first-page":"95","article-title":"State of the art in surgery for early stage NSCLC-does the number of resected lymph nodes matter?","volume":"3","author":"Vielva","year":"2014","journal-title":"Transl Lung Cancer Res"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"815","DOI":"10.21037\/tlcr-20-1024","article-title":"A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancer.","volume":"10","author":"Zhu","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ejcts\/ezy311","article-title":"Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis.","volume":"55","author":"Chiappetta","year":"2019","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:05:04Z","timestamp":1746327904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":24,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035341","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]}}}